FdaApplication
BLA 761053
Identifiers
- fda_app_no: BLA761053
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2017-03-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OCREVUS | OCRELIZUMAB | 300MG/10ML (30MG/ML) | Injection |
1 product